Quick Answer
MAIA Biotechnology, Inc. reported Earnings Per Share Diluted of $0.70 (loss) per share for the year ending 2025.
- MAIA Biotechnology, Inc. showed an increase of +33.3% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from MAIA Biotechnology, Inc.'s annual report (Form 10-K), filed with the SEC on March 23, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: $0.78 (loss) per share | Q3 2021: $1.02 (loss) per share | Q1 2022: $0.50 (loss) per share | Q2 2022: $0.40 (loss) per share | Q3 2022: $0.48 (loss) per share | Q1 2023: $0.38 (loss) per share | Q2 2023: $0.35 (loss) per share | Q3 2023: $0.36 (loss) per share | Q1 2024: $0.46 (loss) per share | Q2 2024: $0.40 (loss) per share | Q3 2024: $0.11 (loss) per share | Q1 2025: $0.16 (loss) per share | Q2 2025: $0.18 (loss) per share | Q3 2025: $0.27 (loss) per share.
- Over the full 5 years of available data (2021 to 2025), MAIA Biotechnology, Inc.'s Earnings Per Share Diluted has grown by 70.5%.
- Historical annual values: Fiscal year 2025: $0.70 (loss) per share | Fiscal year 2024: $1.05 (loss) per share | Fiscal year 2023: $1.49 (loss) per share | Fiscal year 2022: $1.75 (loss) per share | Fiscal year 2021: $2.37 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: